Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Mann

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
Annals of Surgical Oncology|July 12, 2008
Predictors of surgical margin status in breast-conserving surgery within a breast screening programEmil D Kurniawan, Matthew H Wong, Imogen Windle, et al.
Clinical & Experimental Metastasis|April 18, 2013
Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasisMasataka Matsumoto, Sally Roufail, Rachael Inder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2017
Relationship of the Breast Ductal Carcinoma <i>In Situ</i> Immune Microenvironment with Clinicopathological and Genetic FeaturesShona Hendry, Jia-Min B Pang, David J Byrne, et al.
Nature|October 7, 2021
Colorimetric histology using plasmonically active microscope slidesEugeniu Balaur, Sandra O' Toole, Alex J Spurling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study GroupAlessandro Testori, Jon Richards, Eric Whitman, et al.
International Journal of Molecular Sciences|November 9, 2024
Discovery of Plasma Lipids as Potential Biomarkers Distinguishing Breast Cancer Patients from Healthy ControlsDesmond Li, Kerry Heffernan, Forrest C Koch, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2016
Patient-reported outcomes in ductal carcinoma in situ: A systematic reviewMadeleine T King, Zoë E Winters, Ivo A Olivotto, et al.
ANZ Journal of Surgery|November 27, 2019
Window of opportunity treatment in breast cancerJulia Chen, Neshanth Easwaralingam, Sanjay Warrier, et al.
Breast (Edinburgh, Scotland)|October 8, 2021
Factors involved in treatment decision making for women diagnosed with ductal carcinoma in situ: A qualitative studyAmy Hatton, Natalie Heriot, John Zalcberg, et al.
Australian Journal of Primary Health|February 24, 2015
Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?Kelly-Anne Phillips, Emma J Steel, Ian Collins, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Annals of Surgical Oncology|July 12, 2008
Predictors of surgical margin status in breast-conserving surgery within a breast screening programEmil D Kurniawan, Matthew H Wong, Imogen Windle, et al.
Clinical & Experimental Metastasis|April 18, 2013
Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasisMasataka Matsumoto, Sally Roufail, Rachael Inder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2017
Relationship of the Breast Ductal Carcinoma <i>In Situ</i> Immune Microenvironment with Clinicopathological and Genetic FeaturesShona Hendry, Jia-Min B Pang, David J Byrne, et al.
Nature|October 7, 2021
Colorimetric histology using plasmonically active microscope slidesEugeniu Balaur, Sandra O' Toole, Alex J Spurling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study GroupAlessandro Testori, Jon Richards, Eric Whitman, et al.
International Journal of Molecular Sciences|November 9, 2024
Discovery of Plasma Lipids as Potential Biomarkers Distinguishing Breast Cancer Patients from Healthy ControlsDesmond Li, Kerry Heffernan, Forrest C Koch, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2016
Patient-reported outcomes in ductal carcinoma in situ: A systematic reviewMadeleine T King, Zoë E Winters, Ivo A Olivotto, et al.
ANZ Journal of Surgery|November 27, 2019
Window of opportunity treatment in breast cancerJulia Chen, Neshanth Easwaralingam, Sanjay Warrier, et al.
Breast (Edinburgh, Scotland)|October 8, 2021
Factors involved in treatment decision making for women diagnosed with ductal carcinoma in situ: A qualitative studyAmy Hatton, Natalie Heriot, John Zalcberg, et al.
Australian Journal of Primary Health|February 24, 2015
Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?Kelly-Anne Phillips, Emma J Steel, Ian Collins, et al.
Pageof 12